Efficacy News and Research

RSS

INRS professors develop innovative strategy to identify leishmanicidal molecules

Leishmania is a microorganism that enters the human body via a sandfly bite. Instead of fleeing the white blood cells deployed by the immune system to destroy it, the parasite allows itself to be swallowed up.

24 Aug 2018

MDA announces 34 new grants totaling $9.9 million to accelerate neuromuscular research

The Muscular Dystrophy Association today announced the award of 34 new grants totaling more than $9.9 million for its summer round of funding. These new grants represent a continued commitment by MDA to fund groundbreaking research that will accelerate treatments and cures for the more than 40 diseases in its program.

24 Aug 2018

UAB receives NIH grant to continue evaluation of new medication for IPF

The University of Alabama at Birmingham has received a grant from the National Institutes of Health totaling $8.9 million to fund a multiyear program evaluating the role of a new medication in a clinical trial for patients suffering from idiopathic pulmonary fibrosis

24 Aug 2018

Penn Nursing professor's book about children and drug safety wins Arthur J. Viseltear Prize

Cynthia Connolly's, PhD, RN, FAAN, book, Children and Drug Safety: Balancing Risk and Protection in Twentieth Century America, just received the distinguished Arthur J. Viseltear Prize.

23 Aug 2018

Study provides new clues to connection between aging and neurodegeneration

For decades researchers have worked to shed light on the causes of neurodegenerative disorders, a group of devastating conditions, including Alzheimer's and Parkinson's, that involve the progressive loss of neurons and nervous system function. In recent years, numerous factors, from genetic mutations to viral infections, have been found to contribute to the development of these diseases.

23 Aug 2018

Researchers complete testing a new drug to treat rheumatoid arthritis

An international research group led by Charité - Universitätsmedizin Berlin has completed testing a new drug to treat rheumatoid arthritis.

23 Aug 2018

Kwashiorkor may be local phenomenon underestimated by national statistics, reveals study

Kwashiorkor, one of the most extreme forms of malnutrition, is estimated to affect more than a hundred thousand children annually.

23 Aug 2018

AVITA Medical: Clinical trial results demonstrate safety, efficacy of RECELL Device in treating burn patients

AVITA Medical today announced that results from two U.S. pivotal clinical trials demonstrating the effectiveness and clinical benefits of the RECELL Autologous Cell Harvesting Device were presented in the plenary session at the U.S. Defense Department Military Health System Research Symposium (MHSRS) in Kissimmee, Florida.

23 Aug 2018

Eisai: EC approves marketing of LENVIMA as first-line treatment for hepatocellular carcinoma

Eisai Co., Ltd. and Merck & Co., Inc., Kenilworth N.J., U.S.A., known as MSD outside of the United States and Canada, announced today that the European Commission has granted a marketing authorization for the oral receptor tyrosine kinase inhibitor LENVIMA (lenvatinib mesylate) as a single agent for the first-line treatment of adult patients with advanced or unresectable hepatocellular carcinoma who have received no prior systemic therapy.

23 Aug 2018

FDA approves first drug for treatment of rare disease affecting the cornea

The U.S. Food and Drug Administration today approved the first drug, Oxervate (cenegermin), for the treatment of neurotrophic keratitis, a rare disease affecting the cornea (the clear layer that covers the colored portion of the front of the eye).

23 Aug 2018

Grim updates on Ebola outbreak in Congo

According to the health ministry, there have been five new cases of Ebola and five deaths from haemmorhagic fever. Ebola cases now sum up at 96 (5 new cases) from the town of Mabalako-Mangina. A total of 69 are confirmed. 55 people have died.

22 Aug 2018

Scientists gain new insight into the immune system and infections

Researchers from Sydney have found that the body contains a special structure that can act as front line soldiers in case of infections. These are the cells that could be the main agents in preserving vaccine-memory, they find.

22 Aug 2018

Surgically-removed tumor specimens can help quickly evaluate cancer drug efficacy

Genetic differences can affect the susceptibility of cancer cells to different drugs. In a new Molecular Oncology study, investigators show that surgically-removed breast and prostate tumor specimens can be used to rapidly screen different drugs to see which ones most effectively target an individual's cancer cells.

22 Aug 2018

Biorhythms and birth control: FDA stirs debate by approving ‘natural’ app

The Food and Drug Administration took a "big tent" approach earlier this month when it approved two new forms of birth control that prevent pregnancy in very different ways.

21 Aug 2018

New drug shows potential to prevent painful side effect of therapy

About 50,000 people in the U.S. are diagnosed annually with head, neck, nasal and oral cancers. Most are treated with radiation, and of those, 70-80 percent develop a painful and debilitating side effect called severe oral mucositis.

20 Aug 2018

New drug- free, nanotechnology-based method detects and treats oral plaque

When the good and bad bacteria in our mouth become imbalanced, the bad bacteria form a biofilm (aka plaque), which can cause cavities, and if left untreated over time, can lead to cardiovascular and other inflammatory diseases like diabetes and bacterial pneumonia.

17 Aug 2018

Less-invasive options are slowing disease progression in glaucoma patients

Judith Smith, now 71, was at a routine appointment several years ago with her longtime ophthalmologist when the doctor made a comment that her right eye looked a little suspicious for glaucoma, an incurable disease that occurs when the optic nerve is damaged by pressure building inside the eye.

17 Aug 2018

OHSU professor conducts clinical trial with artificial pancreas using Xeris' liquid glucagon

Xeris Pharmaceuticals, Inc., a specialty pharmaceutical company leveraging its novel technology platforms to develop and commercialize ready-to-use injectable and infusible drug formulations, announced today that Jessica Castle, M.D., an associate professor of medicine in the OHSU School of Medicine and OHSU Harold Schnitzer Diabetes Health Center in Portland, Oregon, is conducting a clinical trial with a dual-hormone artificial pancreas using Xeris' ready-to-use liquid glucagon to evaluate a new closed-loop algorithm.

17 Aug 2018

Statins may improve conditions of people with rare lung disease

In the first study of its kind, researchers have found that cholesterol-lowering statins may improve the conditions of people with a rare lung disease called autoimmune pulmonary alveolar proteinosis. The research also suggested that two new tests could help diagnose the condition.

17 Aug 2018

$New algorithm helps identify and manage diabetic patients at increased fracture risk$

New algorithm helps identify and manage diabetic patients at increased fracture risk

Fragility fractures are a serious yet neglected complication of both type 1 and type 2 diabetes, with increased risk of fragility fractures in people with diabetes extending across the life span.

17 Aug 2018

Efficacy News and Research

INRS professors develop innovative strategy to identify leishmanicidal molecules

MDA announces 34 new grants totaling $9.9 million to accelerate neuromuscular research

UAB receives NIH grant to continue evaluation of new medication for IPF

Penn Nursing professor's book about children and drug safety wins Arthur J. Viseltear Prize

Study provides new clues to connection between aging and neurodegeneration

Researchers complete testing a new drug to treat rheumatoid arthritis

Kwashiorkor may be local phenomenon underestimated by national statistics, reveals study

AVITA Medical: Clinical trial results demonstrate safety, efficacy of RECELL Device in treating burn patients

Eisai: EC approves marketing of LENVIMA as first-line treatment for hepatocellular carcinoma

FDA approves first drug for treatment of rare disease affecting the cornea

Grim updates on Ebola outbreak in Congo

Scientists gain new insight into the immune system and infections

Surgically-removed tumor specimens can help quickly evaluate cancer drug efficacy

Biorhythms and birth control: FDA stirs debate by approving ‘natural’ app

New drug shows potential to prevent painful side effect of therapy

New drug- free, nanotechnology-based method detects and treats oral plaque

Less-invasive options are slowing disease progression in glaucoma patients

OHSU professor conducts clinical trial with artificial pancreas using Xeris' liquid glucagon

Statins may improve conditions of people with rare lung disease

New algorithm helps identify and manage diabetic patients at increased fracture risk

Bringing real-time analytics to downstream bioprocess monitoring

Designing fluidic architecture for scalable diagnostic platforms

Evaluating new approaches for rare disease genomics

Latest News